{"ticker": {"uuid": "e4d578b3-8a6d-4687-a221-589ba6630126", "symbol": "SLBT", "name": "SL Science Holding Limited Ordinary Shares", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Free cash flow of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPdi1lUUIxdVlWclE5QWdCeTQ4cHJQb3o4U3ZINS16V2w2Qkh3cjBDbHRRc0tGcWtmVGI1ei12ZXhiaEdXMVZoRmpJYlVSMXp5ZndDTUFHd1VLM1RfU3R1aS1SMVhGVDNtNjlYemNtUmFnRm9GSEV1NF9CUXhNSFVIN2p4blcybEhBTWpNcw?oc=5", "source_name": "TradingView", "published_at": "2026-07-22T20:12:50+00:00", "published_display": "22 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/sl-science-announces-successful-exhibition-120000763.html", "source_name": "GlobeNewswire", "published_at": "2026-07-17T12:00:00+00:00", "published_display": "17 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Price to cash flow ratio of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNa2Zpd2tWaGJ0X1U2aG9fSkdnc2YtTVlGTEZMUnpoSHp1N3Y1M2l2dHRCVkE5WVFESGxnZ0V4dTRrSnQ1SGxIZzJScVBOUG41YTkzV3lFRDhGUTdKejJ4azdxZ01WbXZtT0JFbXlHM3NYb0RHOEM1ZHhTY2VoR2dZU0ZkUlkxejlhTkVFWHp6SnZEQ1BGSFgzaFh5N0ZOZw?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T10:59:09+00:00", "published_display": "12 Jul 2026 10:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Non-controlling/minority interest of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQXy1yUjNtT05Vc3NWVkFnNEwzUkk1QWtmdUU0a1JyWElHa3h5QUI2eXA0cHJXZS1MNHNSTmVfemlVVzNTeU5nc05nNy1ldTRqWEJHYzN1b0VqUzhOaXBPc1pkVHB4MUs1N012Zk43RHRscHlfVjBldWFuU0pfYU5udFViUGRtalZ1SmZMb3lsOFphNEFNb05CYWk4ZjRIb2c?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T09:11:49+00:00", "published_display": "12 Jul 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Net debt of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNZUlzb2d0Rjd6MHJwSWZxV2FTQW12VmpMd2RaMlFWMThXdHB2SVFvRjlNVlp5ZXhqd2JZYWdRa2ZqbzZLck04LXhleWNyLTI5VVZqMDJXM09aaC1oTkxkLTdfcW5xZUkzNGdPb29HSmV1NGtieXlsUzJncjNEVXc0ckY2bHBIcGQ2NVE?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T10:58:05+00:00", "published_display": "11 Jul 2026 10:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Diluted earnings per share (diluted EPS) of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOd1hnVEVlcDJHdFdIeE1RY2I3Mkt2Zzd0WWxEQlc4YjhNcF9YaEp2TlBfMnRLWHQ5aFpTdU5hSTA2NWVHSzl5MDgwWEhOYzRUTUhKQVpLVkFieDhZMkhhQTd6TDZLWXRFMjlzX1drTEZ0d0RHQlhpRmdncFYyU0lQR0xkdzdzTFZPMnJ4UTZobWx1ZUg5ZEI2R1A3YzI1ZWVhY0VhTG9n?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:56:39+00:00", "published_display": "11 Jul 2026 02:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Discontinued operations of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNY1JxQ3JSZllIVk1BSlZ3ZU5zaVkxMjBpcHE2NXJtMUFGOUtSa2huTS1KR19GWFY3U1hjSUFuMW90T2N4LUxSQ2xwMVJfUkZLOGFsS0VoNG9hMEhLdHFjYWhEOGx3SVZ4cVZqeWpPUFpkOV9ydDhkTy03Slk1eVJhd0dDZWJMQklfUEpWa05VVjd3eHl6czVaZFFsR3Z5M0lZLVE?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:49:47+00:00", "published_display": "11 Jul 2026 02:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After tax other income/expense of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPQnRIQTM1dXhMaXdGaGc1OGU2YmV1a3FDZXRUeWhJMW55U0tuLXAxajRlcmJKaTNzaFdPWkxWVXJoNHVpQ2tfbXBoQ05XR3FwUjVoSVpyUUduWUttelJ1M1pXajFLWGZ5aDN1ZVl0NVQyNGwzTE5ZVTR2VUw1M1VWWHFnWDJxRnJKa0NUOWhVaVJxbENzY1lMbmVTYm9vRzZK?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:49:28+00:00", "published_display": "11 Jul 2026 02:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Operating income of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQaUVmYURaOGplVThQbmFFTUZRbDJiWUxqa1Zid1Z3YmpJbUt0MWxzcGw4S3U2YVRjcUV6cHlfV0xfTUdja1RjNTM5MTVDbzdiVXVHR24xV1JIdnh6V3hYSmJzS0dHYUVPR01YQnc1RVJlWXdYTEdENmVNR1ZDUTVYOWlqUXNHVDVYamRHcVg3QU9pQQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:25:07+00:00", "published_display": "11 Jul 2026 02:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cost of goods sold of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPMTBrZXhMZFFGVTVLcXV0eTRmakJ5NkNIWkJHaDViU1BjdnduSkR1RDI4aUZLdC0xSVlxZHdKWlM1SjRjSFdrdWpFYlBxWHhIZWNvV1JhZDY0ZmxXa2tYZFBnLVNTSXYtcV9LZnZRNWJzbUtkQWg4QTJRUGdiRnlsOWxCX2Z3RVhqSm1seURCVXpfTlRI?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:25:03+00:00", "published_display": "11 Jul 2026 02:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EBIT of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNT2V5MFlTeWZScmE1SlRRbHo1Q0hPN2p2RkhsSVFxNndvUGpQLU9MX3U3aXBDWG02clVfTzI3RkxwZXhWMHd6YjlrNmJqekJKTWhfNXprYVh6V0FkYTVMR0FfOWU5dHg2dVFOMF82R2RRNDJYT1V4WFdIZlV3NjJIRG1GMXhVeklN?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T22:40:01+00:00", "published_display": "10 Jul 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Holding Limited Cash Flow \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9NdzVuNlE4ZzhpQlQzekNRSWdzaWpkMmo2eWxoemt3NG0xWmEweFNJSThVNHRNZkpXcWNlTVM0cE05aGZibnJ0amw4bzFLbnkySkNoZlFtaWp2ZmE1OTdrdVBvUURPVFZ5ZkRxcXgxSXY1ekNSMFhuUg?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T19:21:25+00:00", "published_display": "10 Jul 2026 19:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Holding Limited Statistics \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNOWNFdXdqejc2WEluWEFCNEw4X1ZCMUY5Qk11V1hoTVFGcFNyNzlwMEp5Sk1FYzV5YVUwbWJFYzJwSnZ0bUtKZmEyZG1Fc3N2OGR2QnRFQVNDTkFaOHU5dDN3SUZrcWdHaFozYTFVVW11S2dDa0EwYTNJLW1xNXhzc2o4dklDejFL?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T17:59:24+00:00", "published_display": "10 Jul 2026 17:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Holding Limited Financial Statements \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE1EVFNNUFdjYU9sSGxwRFhyTXJrdWtMbDhCc0UwNW5SSkF1eGpnNk80NzkyUlVSaldwM3ItQXBKR3NQSUxGSXlKWkxfQ2JNV3dwNVF4NjV3QktuOTBBMkRHdzBoTGh0SXBhbEdEUVBvU0NmMXhOOS1Z?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T17:29:04+00:00", "published_display": "10 Jul 2026 17:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Submits Orphan Drug Designation Request to FDA for GDT Cell Therapy in Glioblastoma", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/sl-science-submits-orphan-drug-122039522.html", "source_name": "MT Newswires", "published_at": "2026-07-10T12:20:39+00:00", "published_display": "10 Jul 2026 12:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/sl-science-holding-limited-submits-120000437.html", "source_name": "GlobeNewswire", "published_at": "2026-07-10T12:00:00+00:00", "published_display": "10 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Holding Limited Reports Full Year 2025 Financial Results", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/sl-science-holding-limited-reports-211300491.html", "source_name": "GlobeNewswire", "published_at": "2026-06-18T21:13:00+00:00", "published_display": "18 Jun 2026 21:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science\u2019s 2025 revenue fell 35% as R&D spending held at $2.07M", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNLV9vb0s2MDZGZW5Zdzh4R1QxQS1rZXlJNW5GRk1xVk9Qd3EwdXVpNE9iYXc2WG9yRTVvcHhxRGVZcVVENVptLTZ3TU9RaUdCV3hoTU5vN3k0ZHBBN1hNUWZ2WDQ1d05QdDBaMV9vY1RwWHd5VndFay1xbzNveDNSUUx6QXhlY09BZzJpaFoyb0VJVDlwRnRFN2NDWlM2RC1OZHdRTXZrbmZiZTdOc3pkYjdMeEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] SL Science Holding Ltd Current Report (Foreign Issuer) | SLBT SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNYWp3SUdwbXFld1F0Y0ZfR0hkdHdYblVKaTJlZC1KbW5ZRmZOOF85RVBmbTVjLUlfbEhESnhfVkN1dXZ0ZE5aTFpEWEJOTHh1V3V4UXZrWUs4ekpuOTdqLW5COWRBZVUxaE1ndWNtWUNndDFqRVNHQmFNRzU2eDN2OU5EdjgtQjVaMEE1UE1URUhtWFIyVVZhWDBxNjBqeXZDZWZfa19JeWZVQnVPV1B0VmJucE9aUUxtRnc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "by_tier": {"direct": [{"title": "Free cash flow of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPdi1lUUIxdVlWclE5QWdCeTQ4cHJQb3o4U3ZINS16V2w2Qkh3cjBDbHRRc0tGcWtmVGI1ei12ZXhiaEdXMVZoRmpJYlVSMXp5ZndDTUFHd1VLM1RfU3R1aS1SMVhGVDNtNjlYemNtUmFnRm9GSEV1NF9CUXhNSFVIN2p4blcybEhBTWpNcw?oc=5", "source_name": "TradingView", "published_at": "2026-07-22T20:12:50+00:00", "published_display": "22 Jul 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/sl-science-announces-successful-exhibition-120000763.html", "source_name": "GlobeNewswire", "published_at": "2026-07-17T12:00:00+00:00", "published_display": "17 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to cash flow ratio of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNa2Zpd2tWaGJ0X1U2aG9fSkdnc2YtTVlGTEZMUnpoSHp1N3Y1M2l2dHRCVkE5WVFESGxnZ0V4dTRrSnQ1SGxIZzJScVBOUG41YTkzV3lFRDhGUTdKejJ4azdxZ01WbXZtT0JFbXlHM3NYb0RHOEM1ZHhTY2VoR2dZU0ZkUlkxejlhTkVFWHp6SnZEQ1BGSFgzaFh5N0ZOZw?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T10:59:09+00:00", "published_display": "12 Jul 2026 10:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Non-controlling/minority interest of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQXy1yUjNtT05Vc3NWVkFnNEwzUkk1QWtmdUU0a1JyWElHa3h5QUI2eXA0cHJXZS1MNHNSTmVfemlVVzNTeU5nc05nNy1ldTRqWEJHYzN1b0VqUzhOaXBPc1pkVHB4MUs1N012Zk43RHRscHlfVjBldWFuU0pfYU5udFViUGRtalZ1SmZMb3lsOFphNEFNb05CYWk4ZjRIb2c?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T09:11:49+00:00", "published_display": "12 Jul 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Net debt of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNZUlzb2d0Rjd6MHJwSWZxV2FTQW12VmpMd2RaMlFWMThXdHB2SVFvRjlNVlp5ZXhqd2JZYWdRa2ZqbzZLck04LXhleWNyLTI5VVZqMDJXM09aaC1oTkxkLTdfcW5xZUkzNGdPb29HSmV1NGtieXlsUzJncjNEVXc0ckY2bHBIcGQ2NVE?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T10:58:05+00:00", "published_display": "11 Jul 2026 10:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Diluted earnings per share (diluted EPS) of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOd1hnVEVlcDJHdFdIeE1RY2I3Mkt2Zzd0WWxEQlc4YjhNcF9YaEp2TlBfMnRLWHQ5aFpTdU5hSTA2NWVHSzl5MDgwWEhOYzRUTUhKQVpLVkFieDhZMkhhQTd6TDZLWXRFMjlzX1drTEZ0d0RHQlhpRmdncFYyU0lQR0xkdzdzTFZPMnJ4UTZobWx1ZUg5ZEI2R1A3YzI1ZWVhY0VhTG9n?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:56:39+00:00", "published_display": "11 Jul 2026 02:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Discontinued operations of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNY1JxQ3JSZllIVk1BSlZ3ZU5zaVkxMjBpcHE2NXJtMUFGOUtSa2huTS1KR19GWFY3U1hjSUFuMW90T2N4LUxSQ2xwMVJfUkZLOGFsS0VoNG9hMEhLdHFjYWhEOGx3SVZ4cVZqeWpPUFpkOV9ydDhkTy03Slk1eVJhd0dDZWJMQklfUEpWa05VVjd3eHl6czVaZFFsR3Z5M0lZLVE?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:49:47+00:00", "published_display": "11 Jul 2026 02:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After tax other income/expense of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPQnRIQTM1dXhMaXdGaGc1OGU2YmV1a3FDZXRUeWhJMW55U0tuLXAxajRlcmJKaTNzaFdPWkxWVXJoNHVpQ2tfbXBoQ05XR3FwUjVoSVpyUUduWUttelJ1M1pXajFLWGZ5aDN1ZVl0NVQyNGwzTE5ZVTR2VUw1M1VWWHFnWDJxRnJKa0NUOWhVaVJxbENzY1lMbmVTYm9vRzZK?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:49:28+00:00", "published_display": "11 Jul 2026 02:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Operating income of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQaUVmYURaOGplVThQbmFFTUZRbDJiWUxqa1Zid1Z3YmpJbUt0MWxzcGw4S3U2YVRjcUV6cHlfV0xfTUdja1RjNTM5MTVDbzdiVXVHR24xV1JIdnh6V3hYSmJzS0dHYUVPR01YQnc1RVJlWXdYTEdENmVNR1ZDUTVYOWlqUXNHVDVYamRHcVg3QU9pQQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:25:07+00:00", "published_display": "11 Jul 2026 02:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cost of goods sold of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPMTBrZXhMZFFGVTVLcXV0eTRmakJ5NkNIWkJHaDViU1BjdnduSkR1RDI4aUZLdC0xSVlxZHdKWlM1SjRjSFdrdWpFYlBxWHhIZWNvV1JhZDY0ZmxXa2tYZFBnLVNTSXYtcV9LZnZRNWJzbUtkQWg4QTJRUGdiRnlsOWxCX2Z3RVhqSm1seURCVXpfTlRI?oc=5", "source_name": "TradingView", "published_at": "2026-07-11T02:25:03+00:00", "published_display": "11 Jul 2026 02:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EBIT of SL Science Holding Limited \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNT2V5MFlTeWZScmE1SlRRbHo1Q0hPN2p2RkhsSVFxNndvUGpQLU9MX3U3aXBDWG02clVfTzI3RkxwZXhWMHd6YjlrNmJqekJKTWhfNXprYVh6V0FkYTVMR0FfOWU5dHg2dVFOMF82R2RRNDJYT1V4WFdIZlV3NjJIRG1GMXhVeklN?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T22:40:01+00:00", "published_display": "10 Jul 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Holding Limited Cash Flow \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9NdzVuNlE4ZzhpQlQzekNRSWdzaWpkMmo2eWxoemt3NG0xWmEweFNJSThVNHRNZkpXcWNlTVM0cE05aGZibnJ0amw4bzFLbnkySkNoZlFtaWp2ZmE1OTdrdVBvUURPVFZ5ZkRxcXgxSXY1ekNSMFhuUg?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T19:21:25+00:00", "published_display": "10 Jul 2026 19:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Holding Limited Statistics \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNOWNFdXdqejc2WEluWEFCNEw4X1ZCMUY5Qk11V1hoTVFGcFNyNzlwMEp5Sk1FYzV5YVUwbWJFYzJwSnZ0bUtKZmEyZG1Fc3N2OGR2QnRFQVNDTkFaOHU5dDN3SUZrcWdHaFozYTFVVW11S2dDa0EwYTNJLW1xNXhzc2o4dklDejFL?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T17:59:24+00:00", "published_display": "10 Jul 2026 17:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Holding Limited Financial Statements \u2013 NASDAQ:SLBT", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE1EVFNNUFdjYU9sSGxwRFhyTXJrdWtMbDhCc0UwNW5SSkF1eGpnNk80NzkyUlVSaldwM3ItQXBKR3NQSUxGSXlKWkxfQ2JNV3dwNVF4NjV3QktuOTBBMkRHdzBoTGh0SXBhbEdEUVBvU0NmMXhOOS1Z?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T17:29:04+00:00", "published_display": "10 Jul 2026 17:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Submits Orphan Drug Designation Request to FDA for GDT Cell Therapy in Glioblastoma", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/sl-science-submits-orphan-drug-122039522.html", "source_name": "MT Newswires", "published_at": "2026-07-10T12:20:39+00:00", "published_display": "10 Jul 2026 12:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/sl-science-holding-limited-submits-120000437.html", "source_name": "GlobeNewswire", "published_at": "2026-07-10T12:00:00+00:00", "published_display": "10 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science Holding Limited Reports Full Year 2025 Financial Results", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/sl-science-holding-limited-reports-211300491.html", "source_name": "GlobeNewswire", "published_at": "2026-06-18T21:13:00+00:00", "published_display": "18 Jun 2026 21:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SL Science\u2019s 2025 revenue fell 35% as R&D spending held at $2.07M", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNLV9vb0s2MDZGZW5Zdzh4R1QxQS1rZXlJNW5GRk1xVk9Qd3EwdXVpNE9iYXc2WG9yRTVvcHhxRGVZcVVENVptLTZ3TU9RaUdCV3hoTU5vN3k0ZHBBN1hNUWZ2WDQ1d05QdDBaMV9vY1RwWHd5VndFay1xbzNveDNSUUx6QXhlY09BZzJpaFoyb0VJVDlwRnRFN2NDWlM2RC1OZHdRTXZrbmZiZTdOc3pkYjdMeEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] SL Science Holding Ltd Current Report (Foreign Issuer) | SLBT SEC Filing - Form 6-K", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNYWp3SUdwbXFld1F0Y0ZfR0hkdHdYblVKaTJlZC1KbW5ZRmZOOF85RVBmbTVjLUlfbEhESnhfVkN1dXZ0ZE5aTFpEWEJOTHh1V3V4UXZrWUs4ekpuOTdqLW5COWRBZVUxaE1ndWNtWUNndDFqRVNHQmFNRzU2eDN2OU5EdjgtQjVaMEE1UE1URUhtWFIyVVZhWDBxNjBqeXZDZWZfa19JeWZVQnVPV1B0VmJucE9aUUxtRnc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 71, "total_relevant": 28, "sentiment_summary": {"positive": 1, "negative": 1, "neutral": 26, "score": 50, "total": 28, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}, {"event": "earnings", "label": "Earnings", "weight": 5.36, "count": 12}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.2, "count": 4}], "positive_events": 1, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 4.3, "latest_week": "2026-07-17", "one_week_move": -9.1, "four_week_move": -25.7, "twelve_week_move": null, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -12.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 41.3333, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-9.1% over one week, -25.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 57, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 14}, {"label": "Market source", "count": 6}, {"label": "GlobeNewswire", "count": 3}, {"label": "Stock Titan", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "MT Newswires", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 19}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Earnings", "count": 12}, {"label": "Balance sheet", "count": 4}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "19", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-9.1% over one week, -25.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Free cash flow of SL Science Holding Limited \u2013 NASDAQ:SLBT"}], "updated_at": "2026-07-22T23:11:11.042358+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}